4//SEC Filing
Machatha Stephen 4
Accession 0000950170-24-030311
CIK 0001341235other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 8:04 PM ET
Size
10.8 KB
Accession
0000950170-24-030311
Insider Transaction Report
Form 4
Machatha Stephen
Chief Development Officer
Transactions
- Sale
Common Stock
2024-03-11$3.41/sh−18,231$62,102→ 255,032 total - Sale
Common Stock
2024-03-12$3.16/sh−11,537$36,503→ 243,495 total - Award
Stock Option (right to buy)
2024-03-09+405,450→ 405,450 totalExercise: $3.62Exp: 2034-03-08→ Common Stock (405,450 underlying)
Holdings
- 211(indirect: See footnote)
Common Stock
Footnotes (6)
- [F1]These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the settlement of certain time-based restricted stock unit awards.
- [F2]Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $3.27 to $3.58. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]These shares of common stock were sold by the Reporting Person for tax withholding and tax planning purposes in connection with the settlement of certain time-based restricted stock unit awards.
- [F4]Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $3.11 to $3.31. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]These shares are held directly by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership over these shares for purposes of Section 16 or for any other purposes.
- [F6]The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2024.
Documents
Issuer
Aldeyra Therapeutics, Inc.
CIK 0001341235
Entity typeother
Related Parties
1- filerCIK 0001836354
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 8:04 PM ET
- Size
- 10.8 KB